Note 3 - Selected Balance Sheet Data - Changes in Carrying Amount of Goodwill (Details) $ in Thousands |
6 Months Ended |
|---|---|
|
Dec. 31, 2018
USD ($)
| |
| Beginning balance | $ 597,890 |
| Acquisitions (Note 4) | 112,581 |
| Currency translation | (4,116) |
| Ending balance | 706,355 |
| Protein Sciences [Member] | |
| Beginning balance | 347,918 |
| Acquisitions (Note 4) | 13,554 |
| Currency translation | (4,061) |
| Ending balance | 357,411 |
| Diagnostics and Genomics [Member] | |
| Beginning balance | 249,972 |
| Acquisitions (Note 4) | 99,027 |
| Currency translation | (55) |
| Ending balance | $ 348,944 |
| X | ||||||||||
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|